The effects of Pluronic block copolymers on the aggregation state of nystatin

Journal of Controlled Release

Volumn 95, Issue 2, 2004, Pages 161-171

  Croy, Scott R ^a   Kwon, Glen S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Critical aggregation concentration; Nystatin; Pluronics; Polymeric micelles; Solubilization

Indexed keywords

AGGLOMERATION; CRITICAL MICELLE CONCENTRATION; LIGHT SCATTERING; MICELLES; PHOSPHATES;

CRITICAL AGGREGATION CONCENTRATIONS (CAC); PLURONIC HYDROPHOBIC BLOCKS;

BLOCK COPOLYMERS;

COPOLYMER; NYSTATIN; PHOSPHATE; POLOXAMER; POLYMER; PYRENE; SODIUM CHLORIDE;

ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; FLUORESCENCE; FLUORESCENCE POLARIZATION; HYDROPHOBICITY; MICELLE; MICELLIZATION; PARTITION COEFFICIENT; PRIORITY JOURNAL; SOLUBILIZATION; TEMPERATURE DEPENDENCE;

EID: 1242271298     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.11.003     Document Type: Article

References (25)

1. Adams M., Lavasanifar A., Kwon G. Amphiphilic block copolymers for drug delivery. J. Pharm. Sci. 92(7):2003;1343-1355.
2. Kataoka K., Kwon G., Yokoyama M., Okano T., Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J. Control. Release. 24:1993;119-132.
3. Nace V. Nonionic Surfactants: Polyoxyalkylene Block Copolymers. 1996;Marcel Dekker, New York.
4. Kabanov A., Batrakova E., Alakhov V. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release. 82:2002;189-212.
5. Inactive Ingredient Search for Approved Drug Products, "Poloxamer" 2003 (7 November);U.S. Food and Drug Administration, http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
6. Gunderson S., Hoffman H., Ernst E., Pfaller M., Klepser M. In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect. Antimicrob. Agents Chemother. 44(10):2000;2887-2890.
7. Johnson E., Ojwang J., Szekely A., Wallace T., Warnock D. Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. Antimicrob. Agents Chemother. 42(6):1998;1412-1416.
8. Denning D., Warn P. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillis fumigatus with reduced susceptibility to amphotericin B. Antimicrob. Agents Chemother. 43(11):1999;2592-2599.
9. Dismukes W. Introduction to antifungal drugs. Clin. Infect. Dis. 30:2000;653-657.
10. Slain D. Lipid based amphotericin B for the treatment of fungal infections. Pharmacotherapy. 19(3):1999;306-323.
11. Pfaller M., Jones R., Messer S., Edmond M., Wenzel R. National surveillance of nosocomial blood stream infection due to candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis. 31:1998;327-332.
12. Bolard J., Legrand P., Heitz F., Cybulska B. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry. 30:1991;5707-5715.
13. Coutinho A., Prieto M. Self-association of the polyene antibiotic nystatin in dipalmitoylphosphatidylcholine vesicles: a time-resolved fluorescence study. Biophys. J. 69:1995;2541-2557.
14. Gruda I., Dussault N. Effect of the aggregation state of amphotericin B on its interaction with ergosterol. Biochem. Cell. Biol. 66:1988;177-183.
15. Hioka N., Chowdhary R., Chansarkar N., Delmarre D., Sternberg E., Dolphin D. Studies of a benzoporphyrin derivative with Pluronics. Can. J. Chem. 88(10):2002;1321-1326.
16. Espuelas S., Legrand P., Loiseau P., Bories C., Barratt G., Irache J. In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188. Antimicrob. Agents Chemother. 44(8):2000;2190-2192.
17. Castanho M., Coutinho A., Prieto M. Absorption and fluorescence of polyene antibiotics in the presence of cholesterol. J. Biol. Chem. 267(1):1992;204-209.
18. Yu B., Nichols B., Aramwit P., Kwon G. The effect of Pluronics F127 and F68 on the aggregation state and hemolytic activity of nystatin. Park K., Kwon I., Yui N., Jeong S., Park K. Biomaterials and Drug Delivery Toward the New Millenium. 2000;373-381 Han Rim Won Publishing, Seoul.
19. Wilhelm M., Zhao C., Wang Y., Xu R., Winnik M., Mura J., Riess G., Croucher M. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study. Macromolecules. 24:1991;1033-1040.
20. Koslov M., Nubarov N., Batrokova E., Kabanov A. Relationship between Pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass Solutes. Macromolecules. 33:2000;3305-3313.
21. Kabanov A., Nazarova I., Astafieva I., Batrakova E., Alakhov V., Yaroslavov A., Kabanov V. Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules. 28:1995;2303-2314.
22. Armstrong J., Parsonage J., Chowdry B., Leharne S., Mitchell J., Beezer A., Lohner K., Laggner P. Scanning densitometric and calorimetric studies of poly(ethylene oxide)/poly(propylene oxide)/poly(ethylene oxide) triblock copolymers (poloxamers) in dilute aqueous solution. J. Phys. Chem. 97:1993;3904-3909.
23. Wanka G., Hoffman H., Ulbrecht W. Phase diagrams and aggregation behavior of poly(oxyethylene)-poly(oxypropylene)-poly(oxyethylene) triblock copolymers in aqueous solutions. Macromolecules. 27:1994;4145-4159.
24. Kalyanasundaram K., Thomas J.K. Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems. J. Am. Chem. Soc. 99(7):1977;2039-2044.
25. Dong D., Winnik M. The Py scale of solvent polarities. Can. J. Chem. 62:1984;2560-2565.